7
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8719 |
SC99
|
Apoptosis; JAK; STAT | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
SC99 是一种口服有效选择性STAT3抑制剂,靶向 JAK2-STAT3 途径,抑制血小板活化和聚集,有抗骨髓瘤和抗血栓活性。它结合在 JAK2 的 ATP 结合袋中,抑制 JAK2 和 STAT3 的磷酸化。 | |||
T40802 |
Poloxamer 188
|
||
Poloxamer 188, a nonionic linear copolymer possessing surfactant properties, demonstrates anti-thrombotic, anti-inflammatory, and cytoprotective activities across different tissue injury models. | |||
T78666 |
Egaptivon pegol
ARC 1779 |
Integrin | Cytoskeletal Signaling |
Egaptivon pegol (ARC1779)为一种核酸适配体,能够阻断von Willebrand Factor (VWF)与血小板GPIb受体的结合,从而展现其抗血栓功能。 | |||
T62949 | (1R,3S)-THCCA-Asn | ||
(1R,3S)-THCCA-Asn (4j) 是一种凝血酶 (thrombin) 的选择性抑制剂 (IC50: 0.07-0.14 μM),具有抗血栓形成作用。 | |||
T64257 | FXIa-IN-8 | ||
FXIa-IN-8 是一种有效的、选择性的 FXIa 抑制剂 (IC50: 14.2 nM)。FXIa-IN-8 表现出抗血栓形成效果,而且不会提高出血风险及明显的毒性 sup>[1]。 | |||
T75689 | Mumefural | ||
Mumefural,Prunus mumeSieb 加工果实中的一种生物活性成分,具有抑制血小板聚集、显示抗血栓作用及改善认知障碍的功能。 | |||
T78283 |
Caplacizumab
ALX-0081,ALX-0681 |
||
Caplacizumab (ALX-0681)为人源化抗血管性血友病因子(vWF)纳米抗体,具有抑制vWF介导的血小板粘附作用,可阻止微血栓进一步形成。该化合物在血栓性血小板减少性紫癜(TTP)研究中应用。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3P2904 |
α-Linolenic acid
Alpha-Linolenic Acid,Linolenic acid,α-亚麻酸 |
Akt; PI3K | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
α-Linolenic acid (Alpha-Linolenic Acid) 是一种必需脂肪酸,人体无法合成,从种子油中分离得到。它可调节 PI3K/Akt 信号传导,影响血栓形成过程。它具有抗心律失常的特性,并且与心血管疾病和癌症等有关。 | |||
T3809 |
Liriope muscari baily saponins C
|
Others | Others |
Liriope muscari baily saponins C 是一种L. muscari (Decne.) Baily 的主要活性成分。它已被作为肿瘤转移候选药物进行研究。它具有很强的抗炎、免疫药理和心脏保护作用。 | |||
T2S1749 |
Protogracillin
原纤细薯蓣皂甙 |
Others | Others |
Protogracillin 是一种甾体皂苷,分离自Dioscorea zingiberensisWright (DZW) 中。从 DZW 根状茎中获得的甾体皂苷具有抗血栓作用,同时由降低心血管疾病风险的潜力。 | |||
TN1312 |
6-Hydroxykaempferol 3-O-β-D-glucoside
6-Hydroxykaempferol 3-O-beta-D-glucoside,6-羟基山柰酚-3-O-Β-D-葡萄糖苷 |
Others | Others |
6-Hydroxykaempferol 3-O-beta-D-glucoside has anti-thrombotic,and antioxidative activities. | |||
TN2106 |
Protodeltonin
原三角叶皂苷 |
BCL; PARP; Caspase | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair; Proteases/Proteasome |
Protodeltonin may have anti-thrombotic activity by both improving the anticoagulation activity and inhibiting platelet aggregation action. Protodeltonin can inhibit the proliferation of a panel of established human and murine cancer cell lines in vitro. |